Cargando…
Loss of tolerance 5 days after discontinuing sulphonamide introduced via desensitization in delayed reaction
The fixed drug eruption is a non-immediate hypersensitivity reaction to drug, characterized by recurrent erythematous or violaceous, rounded, well-defined border plaques, which always appear in the same location every time the culprit drug is administered. The usual practice is to avoid the drug inv...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896605/ https://www.ncbi.nlm.nih.gov/pubmed/31778467 http://dx.doi.org/10.31744/einstein_journal/2020RC5002 |
_version_ | 1783476816018669568 |
---|---|
author | Pereira, Amanda Rocha Firmino Aun, Marcelo Vivolo Kelmann, Nathália Coelho Portilho Motta, Antônio Abílio Kalil, Jorge Giavina-Bianchi, Pedro |
author_facet | Pereira, Amanda Rocha Firmino Aun, Marcelo Vivolo Kelmann, Nathália Coelho Portilho Motta, Antônio Abílio Kalil, Jorge Giavina-Bianchi, Pedro |
author_sort | Pereira, Amanda Rocha Firmino |
collection | PubMed |
description | The fixed drug eruption is a non-immediate hypersensitivity reaction to drug, characterized by recurrent erythematous or violaceous, rounded, well-defined border plaques, which always appear in the same location every time the culprit drug is administered. The usual practice is to avoid the drug involved and to use a structurally different drug. However, there are situations in which there is no safe and effective therapy. In such situations, desensitization is the only option. We describe the case of a patient who presented fixed eruption due to sulfamethoxazole-trimethoprim, who underwent successful desensitization, but required a repeat procedure twice due to relapse after inadvertent full-dose reintroduction. In non-immediate hypersensitivity reaction to drug, the indication is controversial and there is no technical standardization. Furthermore, the time at which such tolerance is lost after discontinuing the drug involved is unknown. In severe non-immediate reactions of types II and III, desensitization is contraindicated. The patient underwent desensitisation to sulfamethoxazole-trimethoprim three times − the first with recurrence of lesions and the second and third without manifestations, all concluded successfully and with no premedication. |
format | Online Article Text |
id | pubmed-6896605 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Instituto Israelita de Ensino e Pesquisa Albert Einstein |
record_format | MEDLINE/PubMed |
spelling | pubmed-68966052019-12-24 Loss of tolerance 5 days after discontinuing sulphonamide introduced via desensitization in delayed reaction Pereira, Amanda Rocha Firmino Aun, Marcelo Vivolo Kelmann, Nathália Coelho Portilho Motta, Antônio Abílio Kalil, Jorge Giavina-Bianchi, Pedro Einstein (Sao Paulo) Case Report The fixed drug eruption is a non-immediate hypersensitivity reaction to drug, characterized by recurrent erythematous or violaceous, rounded, well-defined border plaques, which always appear in the same location every time the culprit drug is administered. The usual practice is to avoid the drug involved and to use a structurally different drug. However, there are situations in which there is no safe and effective therapy. In such situations, desensitization is the only option. We describe the case of a patient who presented fixed eruption due to sulfamethoxazole-trimethoprim, who underwent successful desensitization, but required a repeat procedure twice due to relapse after inadvertent full-dose reintroduction. In non-immediate hypersensitivity reaction to drug, the indication is controversial and there is no technical standardization. Furthermore, the time at which such tolerance is lost after discontinuing the drug involved is unknown. In severe non-immediate reactions of types II and III, desensitization is contraindicated. The patient underwent desensitisation to sulfamethoxazole-trimethoprim three times − the first with recurrence of lesions and the second and third without manifestations, all concluded successfully and with no premedication. Instituto Israelita de Ensino e Pesquisa Albert Einstein 2019-11-14 /pmc/articles/PMC6896605/ /pubmed/31778467 http://dx.doi.org/10.31744/einstein_journal/2020RC5002 Text en http://creativecommons.org/licenses/by/4.0/ This content is licensed under a Creative Commons Attribution 4.0 International License. |
spellingShingle | Case Report Pereira, Amanda Rocha Firmino Aun, Marcelo Vivolo Kelmann, Nathália Coelho Portilho Motta, Antônio Abílio Kalil, Jorge Giavina-Bianchi, Pedro Loss of tolerance 5 days after discontinuing sulphonamide introduced via desensitization in delayed reaction |
title | Loss of tolerance 5 days after discontinuing sulphonamide introduced via desensitization in delayed reaction |
title_full | Loss of tolerance 5 days after discontinuing sulphonamide introduced via desensitization in delayed reaction |
title_fullStr | Loss of tolerance 5 days after discontinuing sulphonamide introduced via desensitization in delayed reaction |
title_full_unstemmed | Loss of tolerance 5 days after discontinuing sulphonamide introduced via desensitization in delayed reaction |
title_short | Loss of tolerance 5 days after discontinuing sulphonamide introduced via desensitization in delayed reaction |
title_sort | loss of tolerance 5 days after discontinuing sulphonamide introduced via desensitization in delayed reaction |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896605/ https://www.ncbi.nlm.nih.gov/pubmed/31778467 http://dx.doi.org/10.31744/einstein_journal/2020RC5002 |
work_keys_str_mv | AT pereiraamandarochafirmino lossoftolerance5daysafterdiscontinuingsulphonamideintroducedviadesensitizationindelayedreaction AT aunmarcelovivolo lossoftolerance5daysafterdiscontinuingsulphonamideintroducedviadesensitizationindelayedreaction AT kelmannnathaliacoelhoportilho lossoftolerance5daysafterdiscontinuingsulphonamideintroducedviadesensitizationindelayedreaction AT mottaantonioabilio lossoftolerance5daysafterdiscontinuingsulphonamideintroducedviadesensitizationindelayedreaction AT kaliljorge lossoftolerance5daysafterdiscontinuingsulphonamideintroducedviadesensitizationindelayedreaction AT giavinabianchipedro lossoftolerance5daysafterdiscontinuingsulphonamideintroducedviadesensitizationindelayedreaction |